Terms: = Thyroid cancer AND uPA AND Treatment
13 results:
1. In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic thyroid cancer Cell Lines.
Baldini E; Presutti D; Favoriti P; Santini S; Papoff G; Tuccilli C; Carletti R; Di Gioia C; Lori E; Ferent IC; Gagliardi F; Catania A; Pironi D; Tripodi D; D'Andrea V; Sorrenti S; Ruberti G; Ulisse S
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409084
[TBL] [Abstract] [Full Text] [Related]
2. Quercetin Has Antimetastatic Effects on Gastric cancer Cells via the Interruption of upa/upaR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.
Li H; Chen C
Integr Cancer Ther; 2018 Jun; 17(2):511-523. PubMed ID: 28627240
[TBL] [Abstract] [Full Text] [Related]
3. [All-trans retinoic acid improves iodine uptake of thyroid cancer cells via repressing transcriptional activity of β-catenin].
Lan L; Deng W; Chen HL; Huo LL; Deng LL; Zhang GY; Luo Y
Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):553-8. PubMed ID: 26902198
[TBL] [Abstract] [Full Text] [Related]
4. Up-regulation of urinary-type plasminogen activator correlates with high-risk papillary thyroid carcinoma with BRAF(V600E) mutation and its possible molecular mechanism.
Wakasa T; Li Y; Bai Y; Liu Z; Ozaki T; Mori I; Miyauchi A; Kakudo K; Nakamura M
Pathol Res Pract; 2014 Nov; 210(11):733-8. PubMed ID: 25085839
[TBL] [Abstract] [Full Text] [Related]
5. Effects of ulinastatin and docetaxel on breast cancer invasion and expression of upa, upaR and ERK.
Luo J; Sun X; Gao F; Zhao X; Zhong B; Wang H; Sun Z
J Exp Clin Cancer Res; 2011 Jul; 30(1):71. PubMed ID: 21798065
[TBL] [Abstract] [Full Text] [Related]
6. [Beneficial effects of retinoic acid on in vitro invasiveness of human thyroid carcinoma cell lines].
Lan L; Cui D; Luo Y; Shi BY; Deng LL; Zhang GY; Deng W; Wang H
Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(34):2407-11. PubMed ID: 21092511
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and molecular features of papillary thyroid cancer in adolescents and young adults.
Vriens MR; Moses W; Weng J; Peng M; Griffin A; Bleyer A; Pollock BH; Indelicato DJ; Hwang J; Kebebew E
Cancer; 2011 Jan; 117(2):259-67. PubMed ID: 20824721
[TBL] [Abstract] [Full Text] [Related]
8. Inhibitory effects of retinoic acid on invasiveness of human thyroid carcinoma cell lines in vitro.
Lan L; Cui D; Luo Y; Shi BY; Deng LL; Zhang GY; Wang H
J Endocrinol Invest; 2009 Oct; 32(9):731-8. PubMed ID: 19509478
[TBL] [Abstract] [Full Text] [Related]
9. Anaplastic thyroid carcinoma: expression profile of targets for therapy offers new insights for disease treatment.
Wiseman SM; Masoudi H; Niblock P; Turbin D; Rajput A; Hay J; Bugis S; Filipenko D; Huntsman D; Gilks B
Ann Surg Oncol; 2007 Feb; 14(2):719-29. PubMed ID: 17115102
[TBL] [Abstract] [Full Text] [Related]
10. Overexpression of urinary plasminogen activator (upa) protein and mRNA in thyroid carcinogenesis.
Chu QD; Hurd TC; Harvey S; Martinick M; Markus G; Tan D; Gibbs JF; Loree T
Diagn Mol Pathol; 2004 Dec; 13(4):241-6. PubMed ID: 15538115
[TBL] [Abstract] [Full Text] [Related]
11. Beneficial effects of retinoic acid on extracellular matrix degradation and attachment behaviour in follicular thyroid carcinoma cell lines.
Havekes B; Schröder van der Elst JP; van der Pluijm G; Goslings BM; Romijn JA; Smit JW
J Endocrinol; 2000 Nov; 167(2):229-38. PubMed ID: 11054636
[TBL] [Abstract] [Full Text] [Related]
12. Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells.
Ragno P; Montuori N; Covelli B; Hoyer-Hansen G; Rossi G
Cancer Res; 1998 Mar; 58(6):1315-9. PubMed ID: 9515821
[TBL] [Abstract] [Full Text] [Related]
13. Urokinase-type plasminogen-activator receptor associates to a cell surface molecule in monocytic cells.
Ragno P; Montuori N; Rossi G
Biochem Biophys Res Commun; 1996 Jul; 224(1):252-7. PubMed ID: 8694822
[TBL] [Abstract] [Full Text] [Related]
